David Meyer - Aurora Spine Chief VP

All Insiders . USA . 
Stock . Aurora Spine . Stakeholders . Insider . David Meyer
ASAPF Stock  USD 0.31  0.02  6.06%   

Insider

David Meyer is Chief VP of Aurora Spine
Phone760 424 2004
Webhttps://www.aurora-spine.com

David Meyer Latest Insider Activity

Tracking and analyzing the buying and selling activities of David Meyer against Aurora Spine otc stock is an integral part of due diligence when investing in Aurora Spine. David Meyer insider activity provides valuable insight into whether Aurora Spine is net buyers or sellers over its current business cycle. Note, Aurora Spine insiders must abide by specific rules, including filing SEC forms every time they buy or sell Aurora Spine'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
 
David Meyer over six months ago
Disposition of 450 shares by David Meyer of Avista at 36.21 subject to Rule 16b-3
 
David Meyer over six months ago
Acquisition by David Meyer of 55000 shares of Titan Machinery at 18.12 subject to Rule 16b-3

Aurora Spine Management Efficiency

The company has return on total asset (ROA) of (0.0851) % which means that it has lost $0.0851 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2737) %, meaning that it generated substantial loss on money invested by shareholders. Aurora Spine's management efficiency ratios could be used to measure how well Aurora Spine manages its routine affairs as well as how well it operates its assets and liabilities.
Aurora Spine has accumulated 2.27 M in total debt with debt to equity ratio (D/E) of 0.58, which is about average as compared to similar companies. Aurora Spine has a current ratio of 2.38, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Aurora Spine until it has trouble settling it off, either with new capital or with free cash flow. So, Aurora Spine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aurora Spine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aurora to invest in growth at high rates of return. When we think about Aurora Spine's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Itedale RedwanBICO Group AB
N/A
Stuart BernsteinBrain Scientific
N/A
Jason CliftonBICO Group AB
N/A
Daniel CloutierBrain Scientific
57
Lotta BusCellink AB
53
Jason CliftonCellink AB
N/A
Hassan KotobBrain Scientific
59
Mikael EngblomBICO Group AB
46
Erik GatenholmBICO Group AB
34
Lotta BusBICO Group AB
53
Erica BellBICO Group AB
50
Erica BellCellink AB
50
Asa HillstenBICO Group AB
48
Hector MartinezCellink AB
38
Mikael EngblomCellink AB
46
Niclas EmanuelssonBICO Group AB
52
Irina NazarovaBrain Scientific
N/A
Erik GatenholmCellink AB
34
Farid AnthonyBrain Scientific
41
Itedale RedwanCellink AB
N/A
Artur AiraBICO Group AB
56
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. Aurora Spine Corporation was incorporated in 2013 and is headquartered in Toronto, Canada. Aurora Spine is traded on OTC Exchange in the United States. Aurora Spine [ASAPF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Return On Equity-0.27
Return On Asset-0.0851

Aurora Spine Leadership Team

Elected by the shareholders, the Aurora Spine's board of directors comprises two types of representatives: Aurora Spine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aurora. The board's role is to monitor Aurora Spine's management team and ensure that shareholders' interests are well served. Aurora Spine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aurora Spine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Trent Northcutt, President, Founder
David Meyer, Chief VP
Laszlo Garamszegi, CTO Founder
Chad Clouse, Chief Officer

Aurora Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Aurora Spine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.27
Return On Asset-0.0851
Profit Margin(0.11) %
Operating Margin(0.10) %
Current Valuation25.13 M
Shares Outstanding66.73 M
Shares Owned By Insiders17.89 %
Price To Book4.22 X
Price To Sales1.70 X
Revenue10.54 M

Currently Active Assets on Macroaxis

BTCBitcoin
TRXTRON
BNBBinance Coin
ADACardano
XRPXRP

Other Information on Investing in Aurora OTC Stock

Aurora Spine financial ratios help investors to determine whether Aurora OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurora with respect to the benefits of owning Aurora Spine security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY